Moreover, our results from 409 patients with COVID-19 showed that the positive rates of IgM and IgG were both low in early stage (Figure 1 and Supplementary Table S2), and gradually increased with the prolongation of disease courses, which consistent with the previous study [13,17]. This evidence concerns the gene CD40LG and COVID-19.